S-648414 + dolutegravir

S-648414 + dolutegravir is a **combination antiretroviral therapy** under investigation for the treatment of HIV-1 infection. Dolutegravir is a well-established integrase strand transfer inhibitor (INSTI) that blocks HIV integrase and thus prevents integration of viral DNA into the host genome. "S-648414" appears to be a code name for a nonstandard or investigational HIV agent (specific mechanistic or class data are not found in public databases as of the current date). The product is being studied or considered as a dual-drug regimen for HIV-1 infection, potentially to reduce drug burden or address resistance profiles. S-648414's class and mechanism are not established in the public domain, but the combination with dolutegravir suggests a strategy to pair an INSTI with another active antiretroviral agent.